Recombinant Antibodies to Face SARS-CoV-2 Syndemic
Description
In recent years, increasing interest has been paid to using antibody-based therapies for clinical applications. However, it is unclear whether recombinant antibodies can be combined with other scientific approaches to generate innovative solutions
